Smaller Diameter Columns, Larger Benefits

Út, 24.11.2026 11:00 CET
Získejte spolehlivé LC výsledky hned od prvního nástřiku s Waters MaxPeak Premier! Zkracujte kondicionování metod a podpořte udržitelnost své laboratoře.
Waters Corporation: Upcoming events
Waters Corporation: Upcoming events

Reduce Costs, Boost Sensitivity, and Improve Sustainability in LC and LC-MS Analysis

Today's analytical laboratories are expected to do more with less: generate high-quality data, control operating costs, and support sustainability goals.

In this webinar, discover practical approaches to reducing solvent and sample consumption, improving analytical sensitivity, and increasing laboratory productivity without compromising chromatographic performance.

Learn how modern column technologies, including the new 3.0 mm ID and Microflow MaxPeak™ Premier Columns, can help deliver more sustainable and efficient HPLC and UPLC workflows across small molecule, large molecule, omics, and bioanalysis applications. You'll see how reducing column internal diameter can lower solvent and sample consumption while maintaining, and often improving, analytical sensitivity, chromatographic performance, and data quality.

You'll also discover how MaxPeak Premier Technology minimizes analyte adsorption and delivers reliable performance from the very first injection. By reducing method conditioning requirements and improving robustness, laboratories can achieve greater productivity, consistency, and confidence in their analytical results.

Join us to explore how your laboratory can lower costs, improve performance, and advance sustainability initiatives without compromising data quality.

Why you should attend

Attend this webinar to discover practical strategies that can help your laboratory:

  • Reduce the cost of analysis through lower solvent and sample consumption
  • Increase analytical sensitivity while maintaining chromatographic performance
  • Improve laboratory sustainability and support greener analytical workflows
  • Generate reliable results from the very first injection with MaxPeak Premier Technology
  • Reduce method conditioning, repeat analyses, and troubleshooting
  • Increase productivity and throughput without sacrificing data quality
  • Improve confidence in your analytical results through robust and reproducible performance

Who should attend

  • Analytical Scientists
  • Chromatographers
  • QC and QA Laboratories
  • Pharmaceutical and Biopharmaceutical Professionals
  • Environmental and Food Testing Laboratories
  • Sustainability Leaders in Analytical Sciences

Speaker: Philippe Vassault (Market Development Manager, EMEA, Waters Corporation)

Philippe Vassault holds an engineering background in Chemistry and Biology and joined Waters in 2004 during the launch of UPLC technology, contributing to its successful adoption across the market.

Throughout his career at Waters, Philippe has remained deeply committed to helping analytical scientists address complex separation challenges. He began as a Consumables Account Manager, supporting laboratories with application-driven solutions, before specializing in the separation of biomolecules.

He later played a key role in the development of the Biopharma market across Southern Europe, introducing innovative LC and LC-MS technologies that helped customers accelerate their analytical workflows and gain deeper insights into biological systems.

Building on his strong expertise in chromatography columns and consumables, Philippe went on to lead the French Consumables Sales Team. Today, he manages the Pharma Small Molecule Market for EMEA, where he continues to support the adoption of advanced analytical solutions that enable scientists to drive innovation and achieve reliable results.

Speaker: Ali Tiss, Ph.D., MSc., Eng. (Market Development Manager, EMEA, Waters Corporation)

Chemistry Market Development Manager, Biopharma & Cell and Gene Therapies, Waters Corporation.

Ali joined Waters in 2021 and has since supported colleagues and users in the biomolecule separation field (proteins, peptides, Abs, conjugates, Cell & Gene Therapy products). Ali completed his Ph.D. in biochemistry and structural biology at the Mediterranean University (CNRS, Marseille, France), where he contributed to the R&D of the anti-obesity drug, Xenical®, developed by Roche Ltd. Then, he earned over two decades of research experience in biochemistry, liquid chromatography, mass spectrometry, and proteomics, focusing on detecting and characterizing biomarkers related to human diseases such as cancer, diabetes, and obesity. Ali is passionate about supporting customers' business and innovative applications.

Waters Corporation
LinkedIn Logo